Valentina Giorgio
Biographic Data
| ID | 7911675 |
|---|---|
| NAME | Valentina Giorgio |
| GIVEN NAMES | Valentina |
| FAMILY NAME | Giorgio |
| SIGNATURE | GIORGIO V |
| AFFILIATIONS | Agostino Gemelli University Polyclinic |
| ORCID | 0000-0002-7448-8710 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Metabolic Profile of Patients with Smith-Magenis Syndrome
Background : Smith-Magenis syndrome (SMS) is caused by either interstitial deletions in the 17p11.2 region or pathogenic variants in the RAI1 gene and is marked by a distinct set of physical, developmental, neurological, and behavioral features. Hypercholesterolemia has been described in SMS, and obesity is also commonly found. Aim : To describe and characterize the metabolic phenotype of a cohort of SMS patients with an age range of 2.9-32.4 yea…
Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis
The need to develop specific recommendations to guide the use of medications for managing skin reactions induced by anti-TNF-α drugs is herein emphasized
NAFLD-nonalcoholic fatty liver disease in overweight/obese child (ow/ob) born SGA (Small for Gestational Age)
No prominent works on this page.
NAFLD-nonalcoholic fatty liver disease in overweight/obese child (ow/ob) born SGA (Small for Gestational Age)
Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis
The need to develop specific recommendations to guide the use of medications for managing skin reactions induced by anti-TNF-α drugs is herein emphasized
Metabolic Profile of Patients with Smith-Magenis Syndrome
Background : Smith-Magenis syndrome (SMS) is caused by either interstitial deletions in the 17p11.2 region or pathogenic variants in the RAI1 gene and is marked by a distinct set of physical, developmental, neurological, and behavioral features. Hypercholesterolemia has been described in SMS, and obesity is also commonly found. Aim : To describe and characterize the metabolic phenotype of a cohort of SMS patients with an age range of 2.9-32.4 yea…
Internal Medicine (3 works) · Medicine (3 works) · Biology (2 works) · Disease (2 works) · Endocrinology (2 works) · Gastroenterology (2 works) · Obesity (2 works) · Adverse effect (1 work) · Autoimmune and Inflammatory Disorders (1 work) · Birth weight (1 work)